Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC

BSE5861.25-3.15 (-0.05 %)

PREV CLOSE ( ) 5864.40

OPEN PRICE ( ) 5864.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 887

TODAY'S LOW / HIGH ( )5830.00 5979.00

52 WK LOW / HIGH ( )4912.3 6107.55

NSE5854.00-5 (-0.09 %)

PREV CLOSE( ) 5859.00

OPEN PRICE ( ) 5857.00

BID PRICE (QTY) 5854.00 (76)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15274

TODAY'S LOW / HIGH( ) 5830.00 5984.50

52 WK LOW / HIGH ( )4863 6175.5

Select year

(Rs.in Million)

Particulars

Jun 2024

Jun 2023

Jun 2022

Jun 2021

Jun 2020

Profit Before Tax

2733.20

3142.00

2533.70

2332.80

3548.50

Adjustment

522.70

414.90

273.10

408.90

-121.60

Changes In working Capital

-121.20

-300.20

-473.00

412.20

-57.30

Cash Flow after changes in Working Capital

3134.70

3256.70

2333.80

3153.90

3369.60

Cash Flow from Operating Activities

2282.90

2360.10

1695.20

2472.60

2353.70

Cash Flow from Investing Activities

-68.70

-215.00

-255.40

-322.70

1646.40

Cash Flow from Financing Activities

-4181.10

-984.70

-2886.30

-3866.30

-8834.10

Net Cash Inflow / Outflow

-1966.90

1160.40

-1446.50

-1716.40

-4834.00

Opening Cash & Cash Equivalents

4354.20

3194.00

4640.50

6356.90

11190.90

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

2387.30

4354.40

3194.00

4640.50

6356.90